5-(2-(2-azabicyclo[2.1.1]hexan-2-yl)-6-((1S,4S)-2-oxa-5-azabicyclo[2.2.1]heptan-5-yl)pyrimidin-4-yl)-3-(trifluoromethyl)pyrazin-2-amine

ID: ALA5284496

Chembl Id: CHEMBL5284496

Max Phase: Preclinical

Molecular Formula: C19H20F3N7O

Molecular Weight: 419.41

Associated Items:

Names and Identifiers

Canonical SMILES:  Nc1ncc(-c2cc(N3C[C@@H]4C[C@H]3CO4)nc(N3CC4CC3C4)n2)nc1C(F)(F)F

Standard InChI:  InChI=1S/C19H20F3N7O/c20-19(21,22)16-17(23)24-5-14(25-16)13-4-15(28-7-12-3-11(28)8-30-12)27-18(26-13)29-6-9-1-10(29)2-9/h4-5,9-12H,1-3,6-8H2,(H2,23,24)/t9?,10?,11-,12-/m0/s1

Standard InChI Key:  QUJWSXIGZUDUAB-QQFIATSDSA-N

Alternative Forms

  1. Parent:

    ALA5284496

    ---

Associated Targets(Human)

MAP3K12 Tchem Mitogen-activated protein kinase kinase kinase 12 (1076 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MAP3K13 Tchem Mitogen-activated protein kinase kinase kinase 13 (265 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 419.41Molecular Weight (Monoisotopic): 419.1681AlogP: 2.11#Rotatable Bonds: 3
Polar Surface Area: 93.29Molecular Species: NEUTRALHBA: 8HBD: 1
#RO5 Violations: 0HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 4.84CX LogP: 2.70CX LogD: 2.70
Aromatic Rings: 2Heavy Atoms: 30QED Weighted: 0.81Np Likeness Score: -0.51

References

1. Craig RA, Fox BM, Hu C, Lexa KW, Osipov M, Thottumkara AP, Larhammar M, Miyamoto T, Rana A, Kane LA, Yulyaningsih E, Solanoy H, Nguyen H, Chau R, Earr T, Kajiwara Y, Fleck D, Lucas A, Haddick PCG, Takahashi RH, Tong V, Wang J, Canet MJ, Poda SB, Scearce-Levie K, Srivastava A, Sweeney ZK, Xu M, Zhang R, He J, Lei Y, Zhuo Z, de Vicente J..  (2022)  Discovery of Potent and Selective Dual Leucine Zipper Kinase/Leucine Zipper-Bearing Kinase Inhibitors with Neuroprotective Properties in In Vitro and In Vivo Models of Amyotrophic Lateral Sclerosis.,  65  (24.0): [PMID:36469401] [10.1021/acs.jmedchem.2c01056]

Source